MANAGING PHARMACEUTICAL SALES ACTIVITIES IN AN ACADEMIC ANESTHESIOLOGY DEPARTMENT

被引:8
作者
JOHNSTONE, RE
VALENZUELA, RC
SULLIVAN, D
机构
[1] Department of Anesthesiology, Robert C. Byrd Health Sciences Center, Morgantown, WV
[2] Department of Anesthesiology, the College of Law, West Virginia University, Morgantown, WV
关键词
ANESTHESIA; BUSINESS; PHARMACEUTICALS; COSTS; ETHICAL GUIDELINES; MARKETING;
D O I
10.1016/0952-8180(95)00101-M
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
To contain costs, departments of anesthesiology must control the use of new, expensive drugs. Conflicts with pharmaceutical companies can arise when they promote drug sales. Pharmaceutical company sales represent anesthesiology department expenses. Anesthesiologists hold diverse opinions on this clash of interests, on the proper roles of pharmaceutical sales representatives in anesthesiology departments, and on the ethics of accepting industry gifts. Our department has managed pharmaceutical sales activities by encouraging discussion of the ethics and legal limits of industry gifts, by banning sales representatives from bringing food into the department, and by adopting The American Medical Association Guidelines on Gifts.
引用
收藏
页码:544 / 548
页数:5
相关论文
共 30 条
[1]  
Johnstone, Market costs of short-term physician and nurse anesthesia services, J Clin Anesth, 6, pp. 129-132, (1994)
[2]  
Billi, Wise, Middleton, Loney, Tremper, Financial impact of the Medicare Fee Schedule on a department of anesthesiology in an academic medical center: two scenarios, Acad Med, 68, pp. 643-647, (1993)
[3]  
Johnstone, Jozefczyk, Costs of anesthetic drugs: experiences with a cost education trial, Anesth Analg, 78, pp. 766-771, (1994)
[4]  
Orkin, Moving toward value-based anesthesia care, J Clin Anesth, 5, pp. 91-98, (1993)
[5]  
Gannon, Anesthesia drug market climbing through 1999, Hosp Pharm Rep, 7, pp. 32-35, (1993)
[6]  
Saidman, Unresolved issues relating to peer review, industry support of research, and conflict of interest, Anesthesiology, 80, pp. 491-492, (1994)
[7]  
Drake, Uhlman, Making medicine, making money, (1993)
[8]  
Ryan, The rising cost of pharmaceuticals: an industry observer's perspective, Am J Hosp Pharm, 50, pp. S3-S4, (1993)
[9]  
Rock, Cut your spiraling drug costs 70%, Money, (1993)
[10]  
Anders, Costly medicine meets its match: hospitals just use lower doses, Wall Street Journal, pp. A1-A6, (1994)